欧美欧洲成 人在线观看_印度AV无码Av乱码在线_美大色堂在线视频_人人五级片在线播放

PRODUCT DISPLAY

Our company is committed to the research and production of high-purity animal and plant extracts, active pharmaceutical ingredients, cosmetic ingredients, and food additives

Cholic acid series products

Ursodeoxycholic acid, as an active pharmaceutical ingredient, can be used to increase bile acid secretion, alter bile composition, reduce cholesterol and cholesterol lipids in bile, and facilitate the gradual dissolution of cholesterol in gallstones.

Other products

It plays a leading and comprehensive role in anti-aging, antioxidant, anti radiation, beauty, liver protection, treatment of alcoholic liver disease and viral hepatitis, blood sugar control, and blood sugar concentration balance.

ABOUT BELLING

Zhongshan Belling Biotechnology Co., Ltd. was founded on April 6, 2004, located in the National Health Industry Base Park of Torch Development Zone, Zhongshan City, Guangdong Province, with a registered capital of 66.66 million RMB. It is a subsidiary of other limited liability companies. The company was recognized as a national high-tech enterprise in 2009, 2012, 2015, and 2018. In 2013, it was awarded the Guangdong Provincial Engineering Technology Research Center for Animal Medicinal Ingredients. In 2015, it successfully passed the new GMP certification for ursodeoxycholic acid. In May 2018, it was recognized as a provincial-level enterprise technology center in Guangdong Province. In August 2019, it obtained the EU CEP certificate.

20
50
50
1000

Focus on bile acid products

Products sold to countries and regions

Obtaining invention patents and certificates

Annual production of starting materials and active pharmaceutical ingredients

Year

Ton

+

Individual

About Belling

Development History

Business Scope

Our company is committed to the research and production of high-purity animal and plant extracts, active pharmaceutical ingredients, cosmetic raw materials, and food additives. Our leading product...

Our company is a leading enterprise in the domestic liver and gallbladder raw material products. Our company's excellent quality of ursodeoxycholic acid raw material has been widely recognized by domestic...

We look forward to long-term win-win cooperation with excellent international pharmaceutical companies to provide professional services for your products to enter the Chinese market.

GLOBAL MARKET

Belling Biological's bile acid products have been officially approved by China, Taiwan, China, the European Union, India, Russia and other countries, and have two EU CEP certificates for ursodeoxycholic acid. The factory has passed the on-site inspection by the US FDA. Every year, hundreds of tons of bile acid products are sold to nearly 50 countries and regions worldwide, including Germany, Russia, India, the United States, Canada, Japan, Argentina, Egypt, Australia, Brazil, and more. The product market share ranks among the top three globally.

LATEST NEWS

Follow Belling Biotechnology to learn more about the latest information on bile acid products

  • 上海交通大學(xué)基礎(chǔ)醫(yī)學(xué)院程金科課題組在一項(xiàng)最新研究中鑒定了腫瘤免疫抑制的重要調(diào)控因子SENP1，發(fā)現(xiàn)其通過影響MDSC的發(fā)育及功能改變腫瘤進(jìn)程，并提示其在腫瘤臨床治療中的潛在價(jià)值。
    2024-08-02
  • 復(fù)旦大學(xué)藥學(xué)院蔣晨課題組與上海醫(yī)藥工業(yè)研究院陸偉根課題組合作，研發(fā)出一種可重塑腦部病灶神經(jīng)血管單元、治療急性缺血型腦卒中、防止溶栓后副作用的新型聚合物膠束藥物遞送系統(tǒng)。
    2024-08-02
  • 日前，中科院生物物理所范祖森團(tuán)隊(duì)發(fā)現(xiàn)并鑒定了一類新的免疫細(xì)胞亞群：自然殺傷樣B細(xì)胞（NKB cell）。他們還進(jìn)一步探討了這一類免疫細(xì)胞新亞群的發(fā)育來源，證明了NKB與B細(xì)胞從細(xì)胞發(fā)育來源上的不同。
    2024-08-02